XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net income $ 25,849 $ 46,606
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation, amortization and accretion expense 58,214 61,523
Amortization of deferred financing costs 2,806 2,053
Credit loss expense 37 139
Deferred income tax expense (benefit) 1,145 (677)
Equity-based employee and director compensation expense 2,084 1,608
(Gain) loss on dispositions and lease terminations, net (5,220) 620
Changes in operating assets and liabilities, net of acquisitions (5,926) 14,588
Net cash provided by operating activities 78,989 126,460
Cash flows from investing activities:    
Principal payments received on notes receivable 162 102
Proceeds from sale of assets 4,983 4,398
Capital expenditures (21,680) (26,784)
Cash paid in connection with acquisitions, net of cash acquired   (1,885)
Net cash used in investing activities (16,535) (24,169)
Cash flows from financing activities:    
Borrowings under revolving credit facilities 221,900 64,600
Repayments on revolving credit facilities (65,537) (101,815)
Borrowings under the Term Loan Facility   1,120
Repayments on the Term Loan Facility (158,980) (24,600)
Net proceeds from issuance of preferred membership interests   24,430
Payments of finance lease obligations (2,150) (2,030)
Payments of deferred financing costs (7,106) (6)
Distributions paid on distribution equivalent rights (168) (137)
Income tax distributions paid on preferred membership interests (900)  
Distributions paid on common units (59,777) (59,713)
Net cash used in financing activities (72,718) (98,151)
Net (decrease) increase in cash and cash equivalents (10,264) 4,140
Cash and cash equivalents at beginning of period 16,054 7,648
Cash and cash equivalents at end of period $ 5,790 $ 11,788